Wachovia faces Class Action Lawsuit over Evergreen Ultra Short Opportunities Fund

A class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of investors who held shares in Wachovia’s Evergreen Ultra Short Opportunities Fund (NASDAQ: EUBAX, EUBBX, EUBCS, EUBIX), which was also known as the Evergreen Ultra Short Bond Fund prior to August 1, 2005.

On June 19, 2008, Evergreen Investments, which is the money-market division of Wachovia Bank, announced that the Ultra Short Opportunities Fund would be liquidated after it suffered losses of approximately 20%. The losses were tied to heavy investments in mortgage-backed securities, which accounted for over 70% of the assets held by the fund.

The Evergreen Ultra Short Opportunities Fund class action lawsuit alleges that false and misleading statements were made about the investment strategies of the bond fund, which caused substantial losses in a very short amount of time. The complaint alleges that investors were told that the fund’s objective was to: “provide current income consistent with preservation of capital and low principal fluctuation.” However, over-exposure to the subprime mortgage market without diversification, exposed investors to more risk than they thought.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Wachovia’s Evergreen Ultra Short Opportunities Fund is one of several bond funds that have suffered substantial losses this year as a result of investments in the risky mortgage-backed securities involving subprime loans. Thousands of investors who owned shares in the Schwab YieldPlus Fund (SWYPX and SWYSX), as well as investors in various Morgan Keegan bond funds are also pursing lawsuits to recover losses. Ultra short term bond funds are supposed to be relatively conservative investments, and other bond funds in the same class, which were exposed to the same market conditions, did not suffer such dramatic losses.

3 Comments

  • cindeMarch 10, 2011 at 2:17 pm

    I got a check for approx $77 and I don't want to cash it...I had put over $50k in that fund and through 10 yrs they took over $30k from me and can't find it. I think they owe me more than $77.

  • Evergreen Ultra Short Opportunities Fund Settlement Results in $40M Payment - AboutLawsuits.comJune 15, 2009 at 7:58 pm

    [...] be distributed to customers, the settlement does not resolve Evergreens potential liability through Ultra Short Opportunities Fund class action lawsuits and the individual investor [...]

  • THOMASMarch 20, 2009 at 1:16 am

    MY WIFE WORKS FOR THIS SO CALLED BANK, SO I HAVE TO BE CAREFUL????OVER 30 YRS.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Silicosis Lawsuit Filed Against Artificial Stone Manufacturers, Distributors
Silicosis Lawsuit Filed Against Artificial Stone Manufacturers, Distributors (Posted today)

An artificial stone countertop fabricator and installer has filed a lawsuit after he developed a debilitating lung disease, known as silicosis, alleging that manufacturers failed to protect workers from inhaling dangerous amounts of silica dust.

BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal
BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal (Posted 4 days ago)

Days after the FDA announced a BioZorb recall, an Arkansas woman has filed a lawsuit, indicating that her BioZorb tissue marker migrated out of position, causing pain and disfigurement, instead of harmlessly absorbing into the body as advertised.